PRODUCTS
APIs and intermediates
No data

No data

  • Abiraterone and Intermediates
  • Abiraterone and Intermediates
  • Abiraterone and Intermediates
  • Abiraterone and Intermediates
  • Abiraterone and Intermediates
Abiraterone and Intermediates
Abiraterone and Intermediates
Abiraterone and Intermediates
Abiraterone and Intermediates
Abiraterone and Intermediates
+

Share

Abiraterone and Intermediates



Summary:

Abiraterone, also known as 17 - (3-pyridyl) androsterol-5,16-diene-3 β- Alcohol is a synthetic steroid CYP17A1 inhibitor. It is the active metabolite of abiraterone acetate, the ester and prodrug of abiraterone.

CAS:

154229-19-3

Standard:

Enterprise

Purity:


Keywords:

API and Intermediates

  • Product description
  • Product Intro

    Abiraterone is a targeted cytochrome CYP17 (17) α- Hydroxylase / c17,20-lyase) inhibitor produces abiraterone after hydrolysis. Abiraterone acetate inhibits cytochrome CYP17 through chemicalbook, thereby reducing the production of testosterone. It is suitable for the treatment of patients with castrated refractory prostate cancer (CRPC) who have received previous chemotherapy containing docetaxel.

    Function

    Abiraterone is an oral inhibitor of cytochrome oxidase P450 (CYP450) C17. It reduces androgen levels by inhibiting cyp450c17, a key enzyme in androgen synthesis, and inhibits androgens in testis and other parts of the body.

    Application

    Abiraterone is only approved for the treatment of paclitaxel chemotherapy refractory CPRC

Messages

Note: Please provide accurate and detailed information, and our professional staff will contact you as soon as possible!

Recommended products